CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 162 filers reported holding CLOVIS ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $3,375,000 | -64.6% | 500,000 | -66.7% | 0.09% | -76.7% |
Q1 2020 | $9,540,000 | -47.7% | 1,500,000 | -14.3% | 0.40% | -42.8% |
Q4 2019 | $18,244,000 | +828.4% | 1,750,000 | +250.0% | 0.70% | +792.4% |
Q3 2019 | $1,965,000 | -45.3% | 500,000 | +150.0% | 0.08% | -40.6% |
Q4 2018 | $3,592,000 | -21.0% | 200,000 | +100.0% | 0.13% | +37.1% |
Q2 2018 | $4,547,000 | -65.6% | 100,000 | -60.0% | 0.10% | -41.2% |
Q1 2018 | $13,200,000 | -22.4% | 250,000 | 0.0% | 0.16% | -35.8% |
Q4 2017 | $17,000,000 | +79.4% | 250,000 | +117.4% | 0.26% | +57.7% |
Q3 2017 | $9,476,000 | +304.8% | 115,000 | +360.0% | 0.16% | +297.6% |
Q2 2017 | $2,341,000 | +5.4% | 25,000 | -50.0% | 0.04% | -16.3% |
Q4 2016 | $2,221,000 | – | 50,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 407,416 | $18,097,419,000 | 17.62% |
Boxer Capital, LLC | 850,000 | $37,757,000 | 14.60% |
Consonance Capital Management LP | 2,730,887 | $121,306,000 | 13.32% |
Palo Alto Investors LP | 3,804,088 | $168,978,000 | 9.64% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 298,982 | $13,281,000 | 8.01% |
Redmile Group, LLC | 1,620,355 | $71,976,000 | 6.20% |
Crosspoint Capital Strategies, LLC | 84,076 | $3,735,000 | 3.32% |
Ghost Tree Capital, LLC | 220,000 | $9,772,000 | 2.35% |
PointState Capital LP | 3,171,978 | $140,899,000 | 2.03% |
NEA Management Company, LLC | 1,139,890 | $50,634,000 | 2.01% |